FDF CDMO

Daewoong Pharmaceutical offers an integrated development and manufacturing CDMO service

CDMO Service

  • Through 70 years of experience and knowhow, Daewoong initiated CDMO service specializing
    in oral solids and sustained release depot injection
  • Based on our successful experience in commercializing Depot injection, and utilizing our 3 Global
    R&D centers and 7 Manufacturing sites, Daewoong will serve a total solution for your outsourcing needs

Service Range

Service Range
Type Platform technology
  • Product
    Development
  • Commercial
    Manufacturing
  • Regulatory
    Support
Oral
Dosage forms
Conventional Capsule, Tablet (Simple Matrix SR)
Specialized
technology
Modified Release Tab-in-Tab
Double Layered tablet
Multi-filling capsule (Mini tablet)
MUPS (Multiple Unit Pellet System)
BA Enhancement Nano-Crystal
Compliance
Enhancement
Oral dispersible tablet
Chewable tablet
Depot injection Technology Spray-drying, Emulsion, Nano-suspension, Nanotube
Device Dual Chamber Syringe

Business Model

  • Licensing-Out
  • Co-Development
  • Co-Investment &
    development